IL17A and neoplasm: Data regarding the role of IL17 or IL23 in tumor processes derived from mouse models are overall reassuring: Delgado-Ramires et al found that STAT1−/− mice injected with anti-IL-17A developed significantly less tumors compared to STAT1−/− mice injected with isotype antibodies (P < 0.05).